General Info

Noven Pharmaceuticals core business resides in transdermal drug delivery. As a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products, the company s prescription patches are sold in more than 30 countries. Together with Novartis Pharmaceuticals Corporation, the company owns Novogyne Pharmaceuticals, a women s health products company. Among other products, Novogyne markets and sells Noven s Vivelle-Dot product, one of the smallest estrogen patches in the world and one of the most dispensed estrogen patches in the United States. Noven is committed to expanding available transdermal therapies for the benefit of patients, partners and shareholders. Noven Pharmaceuticals is headquartered in Miami.